Results 81 to 90 of about 5,124 (246)
IHJ Cardiovascular Case Reports, 2018 Non-vitamin K antagonist oral anticoagulants are effective for prevention of stroke in atrial fibrillation (AF) but management of emergency situations in some patients receiving these drugs can be challenging.
Manoj Mashru +4 more
doaj +1 more source
Management of acute intracerebral haemorrhage – an update [PDF]
, 2017 Managing acute intracerebral haemorrhage is a challenging task for physicians. Evidence shows that outcome can be improved with admission to an acute stroke unit and active care, including urgent reversal of anticoagulant effects and, potentially ...
Al-Shahi Salman +8 more
core +2 more sources
Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis [PDF]
, 2020 Background Application of idarucizumab and hemodialysis are options to reverse the action of the oral anticoagulant dabigatran in emergency situations.
Fuhr, Laura Maria +3 more
core +1 more source
Journal of Arrhythmia, Volume 41, Issue 1, February 2025.Anticoagulation with direct thrombin inhibitors was a reasonable periprocedural anticoagulation regimen to reduce periprocedural complications in atrial fibrillation ablation. Abstract Background The guidelines recommend anticoagulation management with uninterrupted warfarin or direct thrombin inhibitors (DTIs) during the atrial fibrillation (AF ...
Yuta Taomoto +27 more
wiley +1 more source
Dabigatrán fronte acenocumarol ou warfarina en pacientes con fibrilación auricular [PDF]
, 2018 [Resumo] Introdución: A fibrilación auricular non valvular (FANV) é a arritmia máis frecuente e o ictus a súa principal complicación. Nos pacientes con alto risco de embolización, a terapia anticoagulante demostrou ser altamente eficaz. Os antagonistas
García Costa, Noelia
core
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery [PDF]
, 2017 To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesAstraZeneca Boheringer Ingelheim Abbvie Octapharma Orion ...
Castella, Manuel +12 more
core +2 more sources
Journal of Arrhythmia, Volume 40, Issue 6, Page 1217-1354, December 2024.Abstract In the last three decades, ablation of atrial fibrillation (AF) has become an evidence‐based safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007, the first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence and
Stylianos Tzeis +44 more
wiley +1 more source
Italian Journal of Medicine, 2020 Evaluation of clinical-laboratory-therapeutic management and related clinical outcomes (thrombotic-hemorrhagic complications) of patients undergoing treatment with direct oral anticoagulants (DOACs) during major bleeding. This is a two-year observational
Sara Mascia +7 more
doaj +1 more source
Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes [PDF]
Journal of Stroke, 2018 Oral anticoagulant-associated intracerebral hemorrhage (OAC-ICH) accounts for nearly 20% of all ICH. The number of patients with an indication for oral anticoagulant therapy (OAT) increases with increasing age.
Thorsten Steiner +3 more
doaj +1 more source
Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation [PDF]
, 2018 In today's aging population, urologists are often treating older patients with multiple comorbidities. Lower urinary tract symptoms from benign prostate hyperplasia (LUTS/BPH) is a common condition that affects men, with increasing prevalence as men age.
Heiman, Joshua +2 more
core +1 more source